Vitafol Fe Plus
Generic name: prenatal supplemen
Dosage form: softgel capsule
Medically reviewed by Drugs.com. Last updated on May 1, 2021.
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
On This Page
COMPOSITION
Each PURPLE softgel capsule contains:
|
|
Vitamin A (as beta carotene) | 330 mcg RAE |
Vitamin C (as ascorbic acid) | 60 mg |
Vitamin D (as cholecalciferol) | 25 mcg |
Vitamin E (as dl-alpha tocopheryl acetate) | 9 mg |
Thiamin (Vitamin B1) | 1.6 mg |
Riboflavin (Vitamin B2) | 1.8 mg |
Niacin (as niacinamide) | 15 mg NE |
Vitamin B6 (as pyridoxine hydrochloride) | 2.5 mg |
Folate | 1700 mcg DFE |
(as Folic acid USP 680 mcg DFE; as L-methylfolate calcium 1020 mcg DFE) | |
Vitamin B12 (as cyanocobalamin) | 25 mg |
Iron (as polysaccharide iron complex) | 90 mg |
Iodine (as potassium iodide) | 150 mcg |
Magnesium (as magnesium oxide) | 20 mg |
Zinc (as zinc oxide) | 25 mg |
Copper (as copper oxide) | 2 mg |
Algal oil blend (derived from Natural Algal Oil) | 415 mg* |
Other Ingredients:
Gelatin, Soybean Oil, Sorbitol, Glycerin, Yellow Beeswax, USP Purified Water, Lecithin, Titanium Dioxide (as colorant), FD&C Red #40, FD&C Blue #1, White Edible Ink.
Contains: Soy. May also contain: Corn Oil, DL alpha-tocopherol, Medium ChainTriglycerides.
USAGE
Vitafol® Fe+ prenatal supplement provides vitamin, mineral and omega-3 fatty acid supplementation throughout pregnancy, including individuals with known allergies to fish. Vitafol® Fe+does not contain fish oils, fish proteins, or fish by-products.
Contraindications
Vitafol® Fe+ prenatal supplement is contraindicated in patients with hypersensitivity to any of its components or color additives.
Folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid.
Iron supplementation is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver.
Cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin B12).
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or a Poison Control Center immediately.
WARNINGS/PRECAUTIONS
This product is intended for use as directed by your healthcare provider. Do not share with others. Vitafol® Fe+ must be used with caution in patients with known sensitivity or allergy to soy.
Vitamin D supplementation should be used with caution in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones. High doses of vitamin D can lead to elevated levels of calcium that reside in the blood and soft tissues. Bone pain, high blood pressure, formation of kidney stones, renal failure, and increased risk of heart disease can occur.
Iodine should be used with caution in patients with an overactive thyroid.
Prolonged use of iron salts may produce iron storage disease.
Folic acid, especially in doses above 0.1 mg daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive. The use of folic acid doses above 1 mg daily may precipitate or exacerbate the neurological damage of vitamin B12 deficiency.
Consumption of more than 3 grams of omega-3 fatty acids per day from all sources may lead to excessive bleeding. Supplemental intake of omega-3 fatty acids such as DHA exceeding 2 grams per day is not recommended.
Avoid Overdosage. Keep out of the reach of children.
DRUG INTERACTIONS
Medications for an overactive thyroid (anti-thyroid drugs) used in conjunction with iodine supplementation may lead to hypothyroidism.
Medications for hypertension used in conjunction with iodine supplementation may increase potassium levels in blood.
High doses of folic acid may result in decreased serum levels of the anticonvulsant drugs; carbamazepine, fosphenytoin, phenytoin, phenobarbital, valproic acid. Folic acid may decrease a patient's response to methotrexate.
Vitamin D supplementation should not be given with large amounts of calcium in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones.
Zinc can inhibit the absorption of certain antibiotics; take at least 2 hours apart to minimize interactions.
INFORMATION FOR PATIENTS
Patients should be counseled to disclose all medical conditions, including use of all medications, vitamins and supplements, pregnancy, and breast-feeding.
PEDIATRIC USE
Not for pediatric use.
Adverse Reactions
Adverse reactions have been reported with specific vitamins and minerals, but generally at doses substantially higher than those in Vitafol® Fe+. However, allergic and idiosyncratic reactions are possible at any dose. Reported adverse events include skin ailments, gastrointestinal complaints, glucose abnormalities, and visual problems.
DIRECTIONS FOR USE
Take one purple softgel capsule daily during pregnancy, or as directed by a physician.
How is Vitafol Fe Plus Supplied
Vitafol® Fe+ is available as a purple, oval shaped softgel capsule imprinted "EX0096". Available in box of Unit-Dose pack of 30 (5 child resistant blister cards containing 6 softgel capsules), Item No. 0642-7473-30 and as professional sample Item No. 0642-7473-01 (blister card containing 3 softgel capsules)
Store at room temperature, approximately 15°-30°C (59°-86°F), avoid excessive heat above 30°C (86°F), light and moisture.
Please dispose of any unused capsules promptly, and properly.
You should call your doctor for medical advice about adverse or unexpected reactions. To report to the company an adverse event or obtain product information, call 1-877-324-9349.
Distributed by:
Exeltis USA, Inc.
Florham Park, NJ 07932
1-877-324-9349
www.exeltisusa.com
©2021 Exeltis USA, Inc.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |
Vitafol® is a trademark of Exeltis USA, Inc.
Metafolin® is a trademark of Merck KGaA, Darmstadt, Germany. U.S. Patent No. 6,441,168; 5,997,915; 6,254,904; 6,808,725, 7,172,778 and 7,674,490
Issed: April 2021
4733001-03
PRINCIPAL DISPLAY PANEL - 30 Capsule Dose Pack Box
0642-7473-30
VITAFOL
Fe+
Complete Prenatal Supplement
with 90mg iron
Unit Dose Pack
30 Softgel Capsules
RX
DIETARY SUPPLEMENT
U.S. Patent Pending

Vitafol Fe Plus doconexent, niacinamide, .alpha.-tocopherol acetate, dl-, cholecalciferol, beta carotene, ascorbic acid, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, iron, zinc oxide, cupric oxide, potassium iodide, magnesium oxide, folic acid, and levomefolate calcium capsule, liquid filled |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Labeler - Exeltis USA, Inc. (071170534) |
More about Vitafol Fe Plus (multivitamin, prenatal)
Professional resources
- Other brands
- Prenatal Plus, Concept DHA, Docosavit, Prenatal 19, ... +85 more